" class="no-js "lang="en-US"> Eugene Sayan - Medtech Alert
Thursday, March 20, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Eugene Sayan

Eugene Sayan

About Eugene Sayan

Eugene serves as Softheon’s Founder, Chairman, and Chief Executive Officer, responsible for guiding Softheon’s mission to increase affordability and access to health coverage.

Eugene has over 30 years of experience developing and nurturing technology solutions for healthcare payers, providers, and government agencies. His success at leading multi-year development initiatives stems from his time orchestrating big data and process management projects for Fortune 1000 companies at IBM.

So far in 2022, Eugene earned the Stevie® Silver Award in the Achievement in Management – Health Products & Services category at the 20th Annual American Business Awards®. Additionally, he was recognized as a finalist in the Entrepreneur of The Year® 2022 New York Awards program.

Related Story

Artificial Intelligence

 Softheon Expands to Artificial Intelligence in Care Management for Health Plans through Acquisition of NextHealth Technologies | Pharmtech Focus

Softheon Expands to Artificial Intelligence in Care Management for Health Plans through Acquisition of NextHealth Technologies

July 4 2022

Softheon, a leading cloud-based eligibility, enrollment, and billing provider for health plans and government agencies, has acquired […]